ICHAK YALLIG'LANISHIDA IMMUNITETNING AHAMIYATI
Article Sidebar
Main Article Content
Аннотация:
Ichakning yallig'lanish kasalligi oshqozon ichak traktida yuzaga keladigan surunkali yallig'lanishi bo'lib unga, asosan Kron va yarali kolit kasalliklarini misol kilib keltirish mumkin ichak yallig'lanishi kasalliklarining asosiy sabablaridan bo'lib immunitet tizimining hujayralariga xujum qilishi natijasida yuzaga keladigan yallig'lanish hisoblanadi. Shuning uchun ushbu kasallikni davolash va oldini olishda immun tizimininig yallig'lanishni keltirib chiqarish mehanizmlari haqida bilimga ega bo'lish muhim hisoblanganligi sabablik ushbu maqolada immun tizimining ichak yallig'lanishidagi ahamiyati haqida ma'lumotlar keltirilgan
Ключевые слова:
Article Details
Как цитировать:
Библиографические ссылки:
Shaw MH, Kamada N, Warner N, Kim YG, Nuсez G. The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol. 2011;32:73–79. [PMC free article] [PubMed] [Google Scholar]
Di Sabatino, A. et al. Functional modulation of Crohn’s disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 133, 137–149 (2007)
Henderson Jr WR. The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684–697.)
Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871–1875. 3. Spada CS, Nieves AL, Krauss AH, Woodward DF. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol. 1994;55:183–191.
Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol. 1998;30:173–178. 5. Schoenberger SP. BLT for speed. Nat Immunol. 2003;4:937–939
Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984;86:453– 460.
Peskar BM, Dreyling KW, Peskar BA, May B, Goebell H. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn’s disease: inhibition by sulfasalazine and 5-aminosalicylic acid. Agents Actions. 1986;18:381–383.
. Schmidt C, Kosche E, Baumeister B, Vetter H. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7:865– 869. 9. Lobos EA, Sharon P, Stenson WF. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4. Dig Dis Sci. 1987;32:1380 –1388.
Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn’s colitis, and Clostridium difficile colitis. Gastroenterology. 1988;95:11–17.
Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology. 1986;91:837– 844.
McIntyre TM, Zimmerman GA, Prescott SM. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 1986;83:2204–2208.